Forum Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Out of Business
- Employees
-
187
- Latest Deal Type
-
Out of Business
Forum Pharmaceuticals General Information
Description
Developer of transformative medicines designed to treat brain diseases. The company's transformative medicines explore mechanisms of action to potentially alter the progression of brain disease and provide improvement in cognitive and overall function, enabling patients with central nervous system disorders to get proper treatment.
Contact Information
Website
www.forumpharma.comCorporate Office
- 225 Second Avenue
- Waltham, MA 02451
- United States
Corporate Office
- 225 Second Avenue
- Waltham, MA 02451
- United States
Forum Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 01-Jun-2016 | Completed | Out of Business | |||
| 5. Later Stage VC (Series D) | 31-Oct-2008 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 04-Oct-2006 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 09-Nov-2004 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 03-Oct-2002 | $14.7M | $14.7M | Completed | Startup | |
| 1. Seed Round | Completed | Startup |
Forum Pharmaceuticals Comparisons
Industry
Financing
Details
Forum Pharmaceuticals Competitors (4)
One of Forum Pharmaceuticals’s 4 competitors is Novonco Therapeutics, a Venture Capital-Backed company based in Los Angeles, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novonco Therapeutics | Venture Capital-Backed | Los Angeles, CA | ||||
| Marinus Pharmaceuticals | Private Equity-Backed | Radnor, PA | ||||
| Panbela Therapeutics | Formerly VC-backed | Waconia, MN | ||||
| DBV Technologies | Formerly VC-backed | Chatillon, France |
Forum Pharmaceuticals Patents
Forum Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170247393-A1 | Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors | Inactive | 20-Oct-2015 | ||
| WO-2017069980-A1 | Aminoisoxazoline compounds as agonists of alpha7-nicotinic acetylcholine receptors | Inactive | 20-Oct-2015 | ||
| WO-2017031325-A1 | Oxadiazine compounds and methods of use thereof | Inactive | 18-Aug-2015 | ||
| WO-2017027600-A1 | Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors | Inactive | 12-Aug-2015 | ||
| WO-2016201096-A1 | Aminobenzisoxazole compounds as agonists of a7-nicotinic acetylcholine receptors | Inactive | 10-Jun-2015 | C07D453/02 |
Forum Pharmaceuticals Signals
Forum Pharmaceuticals FAQs
-
When was Forum Pharmaceuticals founded?
Forum Pharmaceuticals was founded in 2001.
-
Where is Forum Pharmaceuticals headquartered?
Forum Pharmaceuticals is headquartered in Waltham, MA.
-
What is the size of Forum Pharmaceuticals?
Forum Pharmaceuticals has 187 total employees.
-
What industry is Forum Pharmaceuticals in?
Forum Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Forum Pharmaceuticals a private or public company?
Forum Pharmaceuticals is a Private company.
-
What is Forum Pharmaceuticals’s current revenue?
The current revenue for Forum Pharmaceuticals is .
-
How much funding has Forum Pharmaceuticals raised over time?
Forum Pharmaceuticals has raised $127M.
-
Who are Forum Pharmaceuticals’s competitors?
Novonco Therapeutics, Marinus Pharmaceuticals, Panbela Therapeutics, and DBV Technologies are competitors of Forum Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process